Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.
Netflix To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…
These Analysts Revise Their Forecasts On D.R. Horton After Q2 Results
D.R. Horton, Inc. (NYSE:DHI) reported better-than-expected second-quarter financial results on Thursday. D.R. Horton posted GAAP EPS of $3.52,…
Investor Optimism Edges Lower; S&P 500 Settles Lower For Fifth Session
The CNN Money Fear and Greed index showed a slight decline in the overall market sentiment, while the index remained in the "Fear" zone on Thursday.
Nasdaq Down 0.5%; Lithium Americas Shares Slide
U.S. stocks traded mostly lower toward the end of trading, with the NASDAQ Composite falling around 0.5% on…
Stocks Edge Higher As Earnings Provide Support, Tesla Sinks To 15-Month Lows, Bitcoin Rebounds: What’s Driving Markets Thursday?
Stocks surged higher on Thursday, with the S&P 500 index aiming to snap a four-day losing streak as investors assess the latest wave of corporate earnings.
Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow…
Why Builder D.R. Horton Shares Are Surging Today
D.R. Horton, Inc. reported Q2 FY24 earnings above estimates with sales and orders increasing. Company updates revenue outlook and declares dividend.
Dow Surges Over 100 Points; D.R. Horton Posts Upbeat Earnings
U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.34% to 37,880.89 while the NASDAQ fell 0.16% to 15,658.94. The S&P 500 also rose, gaining, 0.03% to 5,023.87.
Earnings Scheduled For April 18, 2024
Companies Reporting Before The Bell
• Addex Therapeutics (NASDAQ:ADXN) is estimated to report earnings for its fourth quarter.